Regenerative Medicine Market in the US 2016-2020
Description-
Market
outlook of the Regenerative
Medicine
market in the US
Regenerative
medicine deals with the process of using therapeutically-induced or
laboratory grown human tissue to treat diseased or injured human
cells, tissues, or organs. It is an emerging field of treatment that
helps in producing new cells to substitute malfunctioning or injured
cells as a vehicle to treat disease and injury. The regenerative
medicine market can be characterized into three major modalities,
namely tissue engineering, biomaterials/biomolecules, and stem cell
therapy.
Technavio’s
market research analysts expect the regenerative medicine market in
the US to grow at a fast pace, posting a remarkable CAGR of more than
33% during the forecast period because of the growing demand for
tissue-engineered and stem cell products for the treatment of various
diseases. The potential of these medicines in regenerating diseased
organs is one of the major factors that drives the market in the US.
The stem cells application and advancements in nanotechnology will
further drive the progress in this market.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/regenerative-medicine-market-in-the-us-2016-2020-report.html
Segmentation
by product and analysis of - cell therapy and scaffold
Cell
therapy helps in treating the diseases or to improving the
functioning of the existing cells, by administrating of cells into
the body. This therapy addresses medical conditions related to the
bone, cartilage, heart, skin, digestive system, reproductive system,
eye, blood, spine, brain, and the nervous system. In 2015, cell
therapy segment accounted for approximately 80% of the market share.
The
report offers an analysis of each of the following segments and
discusses its impact on the overall market growth -
• Cell
therapy
• Scaffold
Segmentation
by application and analysis of - dermatology, musculoskeletal,
ocular, and cardiovascular
The
year 2015 saw the precedence of the dermatology segment, accounting
for a market share of more than 51%. Dermatology includes the
treatment of burns and chronic wounds that requires a quick response,
and skin grafting is essential in many cases. Factors such as the
increase in obesity and diabetes, growing elderly population, and an
increase in life expectancy are some of the causes contributing to
the growth of the dermatology market.
The
report offers an analysis of each of the following segments and
discusses its impact on the overall market growth -
• Dermatology
• Musculoskeletal
• Ocular
• Cardiovascular
Competitive
landscape and key vendors - AkzoNobel, Jotun, PPG
Regenerative
medicine market in the US is highly competitive and fragmented
because of the presence of several established vendors and this
competitive environment is expected to intensify with advances in R&D
and technological innovations. International players are likely to
acquire regional or local players to enhance their products and
expand their market share during the forecast period.
The
top vendors in the market are -
• Acelity
• Mesoblast
• Organogenesis
• Reprocell
• Stryker
Other
prominent vendors include Aastrom Biosciences, Acologix, AlloCure,
Allosource, Alphatec Spine, Altrika, Amorcyte, Argos Therapeutics,
Athersys, Avita Medical, Axogen, Bacterin International, Baxter,
Bellicum Pharmaceuticals, BioCardia, BioLife Solutions,
BioRestorative Therapies, BioTissue Technologies, Bluebird Bio,
BrainStorm Cell Therapeutics, Calimmune, Capricor, Celyad (Cardio3
BioSciences), Cell Medica, Cesca, CryoLife, Cynata Therapeutics,
Cytori, Cytori Therapeutics, Dendreon, DiscGenics, Fate Therapeutics,
Fibrocell, Fibrocell Science, Forticell Bioscience, Fortress Biotech,
Gamida Cell, Geron, Harvard Apparatus Regenerative Technology,
Healthpoint, Histogen, Histogenics, Humacyte, Immunocellular
Therapeutics P, Integra Life Sciences, Intercytex, InVivo
Therapeutics, iSTO Technologies, Juventas Therapeutics, Kensey Nash,
Kiadis Pharma, Kinetic Concept, Living Cell Technologies, MaxCyte,
Medtronics, Mesoblast, MiMedix Group, Nanofiber Solutions CTO,
Nanotope, Neuralstem, Newlink Genetics, Northwest Biotherapeutics,
NovaRx, Ocata Therapeutics, Opexa , Therapeutics, Organovo Holdings,
Orteq, Orthofix, Osiris Therapeutics, Osteotech, Pfizer, Pluristem
Therapeutics, Prima BioMed, Q Therapeutics, RhinoCyte, RTI Surgical,
SanBio, Sangamo, Shire Regenerative Medicine, StemCells, Stratatech,
TEI Biosciences, Tengion, Thermo Fischer Scientific, TiGenix, Tissue
Genesis, TissueGene, VentriNova, Vericel, ViaCyte, Vistagen, and
Zimmer.
Key
questions answered in the report include
• What
will the market size and the growth rate be in 2020?
• What
are the key factors driving the regenerative medicine market in the
US?
• What
are the key market trends impacting the growth of the regenerative
medicine market in the US?
• What
are the challenges to market growth?
• Who
are the key vendors in the regenerative medicine market in the US?
• What
are the market opportunities and threats faced by the vendors in the
regenerative medicine market in the US?
• What
are the key outcomes of the five forces analysis of the regenerative
medicine market in the US?
Table
of Contents
PART
01: Executive summary
Highlights
PART
02: Scope of the report
Market
overview
Top
vendor offerings
PART
03: Market research methodology
Research
methodology
Economic
indicators
PART
04: Introduction
Key
market highlights
PART
05: Gene therapy: An emerging field in regenerative medicine
PART
06: Pipeline portfolio
PART
07: Regulatory scenario
FDA
process
PART
08: Market landscape
Market
overview
Market
size and forecast
Five
forces analysis
PART
09: Market segmentation by product
Cell
therapy
Cell
therapy market in US
Scaffold
Scaffold
market in US
PART
10: Market segmentation by application
Dermatology
Musculoskeletal
Ocular
Cardiovascular
PART
11: Market drivers
Rise
in prevalence of chronic diseases
Technological
innovations
Increase
in investment for research and development activities
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment